Rare Hematology Integration Lead (Sr. Director)

Role Summary

The Sr Director Rare Hematology Integration Lead is an integral member of the Global Medical Affairs Therapeutic Area team. The Rare Hematology Integration Lead has strong medical knowledge in Rare Hematology ie Hemophila and Sickle Cell Disease as well as expertise leading, developing, executing evidence generation activities. The purpose of the role is to leverage their therapeutic knowledge to develop the medical evidence generation strategy and tactics for Rare Hematology and liaison with cross-functional teams to integrate critical medical evidence throughout the lifecycle of the medicine. This role will work closely with the Medical Asset leads to determine the medical evidence strategy and work cross-functionally to execute these projects. This leader will partner and collaborate with PRD , Commercial, Value and Evidence, digital, and external KOLs, academic and medical institutions, professional associations, and community networks to improve the safe and effective use of our medicine via generating high quality evidence. This leader has expertise in methodologies, Pfizer systems, and processes involved with MA evidence generation and is responsible for defining and executing the strategy and tactics for Rare Hematology evidence generation activities. The Integration Lead will establish and maintain the highest medical professionalism and scientific excellence standards within RDMA, so MA may maintain their excellent reputation and act as respected peers to external stakeholders. This role will coordinate activities between Global and Local (the countries) to maximize utility for as many countries as possible. The position has broad impact throughout the organization and requires a medical professional with an understanding of the global pharmaceutical industry, products, strategic thinking skills, leadership ability, and strong knowledge about the RD stakeholder community and medical affairs within the industry. Most importantly, this leader puts patients first when developing the strategy and tactics for medical evidence generation.

Responsibilities

• Provide strategic leadership and guidance to cross functional teams on the development and delivery of fully integrated global evidence strategy and the evidence blueprint in Rare Hematology. Studies would include effectiveness/cost-effectiveness research, patient journeys and identification, externally sponsored studies, diagnostic support, digital health endpoints and AI algorithms, non-indication seeking interventional studies and NIS.
• Proactively works with cross-functional teams (e.g., PRD/clinical affairs, regional medical teams, global Health and value, digital, statistics, external stakeholders) to identify medical evidence needs and works interactively to develop innovative research initiatives to address such needs.
• Prioritize, develop, and deliver on evidence plans based on needs and insights of external customers, including internal ways of working, external partnerships. Standardize and streamline internal ways of working.
• Partner with asset teams to drive the Asset Evidence Blueprint development for applicable Rare Disease assets per the LNG framework.
• Conduct gap analyses and determine the RWE needs for external communication in Rare Hematology partnering with field medical, RD GMA leaders, commercial, Health and Value and key countries
• Identify external partnerships for key data needs
• Map out medical community needs, evidence gaps, prioritization evaluation for Rare Hematology to bridge these gaps
• Serve as the liaison to the Medical Affairs Evidence Generation group for overseeing and coordinating operational aspects of studies.
• Partner with the global, local country, US, International medical affairs leads to align on most effective evidence generation strategies
• Work with internal and external experts to publish data at scientific congresses and in peer-reviewed journals
• Establish a culture of scientific excellence and medical professionalism as a guiding principle
• Anticipates and influences continuous improvement and innovation in day-to-day evidence generation and the integration of the evidence within medical and commercial resources

Qualifications

• Required: 10+ years of pharmaceutical industry, academic centers, clinical practice, or a combination of these
• Required: Deep understanding of Pfizer systems and processes related to data generation
• Required: Previous experience leading Real World Evidence projects
• Required: Very strong communications and relationship building capacity
• Required: Strong strategic mindset, understanding of medical affairs, clinical development, health policy/public health and technology
• Required: Demonstration of leading innovative projects
• Required: Candidate demonstrates a breadth of experience and capabilities including: the ability to influence and collaborate with peers, matrix leadership, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create impact
• Preferred: In depth experience with Rare Hematology
• Preferred: Patient care and/or medical affairs experience in Rare Hematology
• Preferred: Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Education

• PharmD, PhD, or equivalent terminal doctoral degree

Additional Requirements

• Up to 25% travel including international travel